Prot#GS-US-428-4194: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis

Project: Research project

Project Details

StatusActive
Effective start/end date6/5/196/5/22

Funding

  • Pharmaceutical Research Associates, Inc. (Prot#GS-US-428-4194)
  • Gilead Sciences, Inc. (Prot#GS-US-428-4194)